课题基金 / 基金详情

Involvement of myelin integrity in Alzheimer's disease pathogenesis

Involvement of myelin integrity in Alzheimer's disease pathogenesis
髓磷脂完整性参与阿尔茨海默病发病机制
批准号:
9267404
负责人:
ADAM D BACHSTETTER
金额:
$24.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2019-04-30
关键词:
Alzheimer&aposs DiseaseAmyloid beta-Protein PrecursorAnimal ModelAreaAutomobile DrivingAutopsyBiochemistryBiologyBrainBrodmann&aposs areaCentral Nervous System DiseasesCerebrumChronicClinicalCognitiveCommunicationDataDeteriorationDevelopment PlansDiffusion Magnetic Resonance ImagingDiseaseDisease ProgressionEducational process of instructingEnvironmentEnzyme-Linked Immunosorbent AssayEventExhibitsGenesGeneticGoalsGrowthHealthHumanImmunohistochemistryInduced MutationInflammationInflammatoryInflammatory ResponseInterleukin-1 betaInternationalKentuckyLate Onset Alzheimer DiseaseMAPT geneMeasuresMedialMediatingMental disordersMentorsMethodsMicrogliaMusMutationMyelinMyelin ProteinsNeocortexNeuregulin 1Neurodegenerative DisordersNeurofibrillary TanglesNeurogliaNeuronsOligodendrogliaPathogenesisPathologicPathologyPathway interactionsPhaseResearchResearch PersonnelResearch Project GrantsResourcesRoleSamplingScientistSenile PlaquesStructureSynapsesTNF geneTemporal LobeTestingTissuesTrainingUniversitiesWhite Matter DiseaseWorkWritingamnestic mild cognitive impairmentaxon injurybeta-site APP cleaving enzyme 1brain tissueburden of illnesscareercareer developmentcollaborative environmentcytokinedesigndigitalfeedingfrontal lobegenetic risk factorgray matterhTau Micehuman tissuehyperphosphorylated tauimprovedinhibitor/antagonistinsightlipid transportmeetingsmouse modelmyelinationneuroinflammationneuron lossneuropathologypre-clinicalpublic health relevanceresponseskillswhite matterwhite matter changeyoung adult

项目摘要

项目成果

ADAM D BACHSTETTER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):此K99/R 00应用程序提供职业发展培训和研究计划,以进一步了解阿尔茨海默病(AD)背景下白色物质中的神经胶质反应。要测试的假设是,在AD中发生髓鞘完整性的进行性丧失,激活小胶质细胞朝向促炎前馈回路,其介导微管相关蛋白tau的过度磷酸化和传统AD病理学:神经炎斑(NP)和神经纤维缠结(NFT)。AD通常被认为是CNS灰质疾病,也具有脑白色物质的显著和进行性恶化。最近的证据表明,髓鞘完整性的变化可能是驱动AD病理学的早期因素,通过刺激炎性小胶质细胞活化和随后的轴突损伤。尽管我们和其他人已经发现AD白色物质中的小胶质细胞和炎症反应比灰质中的小胶质细胞和炎症反应更强烈,但已经做了大量的工作来了解AD灰质中的胶质细胞反应,但对AD白色物质中的小胶质细胞活化知之甚少。没有研究系统地和定量地研究髓鞘变化和炎症特征作为疾病进展的函数。我们的项目将通过使用人类尸检组织和表现出髓鞘完整性丧失的小鼠模型来填补这一空白,以验证我们的假设。我们的具体目标是:1)量化髓鞘完整性,小胶质细胞激活, 促炎细胞因子水平,和尸检样品的白色物质中AD负荷(NP和NFT)的传统测量; 2)确定hTau小鼠中由PLP突变诱导的髓鞘完整性的丧失是否会加速过度磷酸化的tau病理,以及这种病理是否可以通过使用神经胶质细胞因子抑制剂抑制慢性神经炎症来挽救。该项目利用了肯塔基州大学强大的科学环境和广泛的资源,包括阿尔茨海默病中心,临床上特征良好的尸检病例,跨越疾病病理连续体,以及热情而坚定的指导团队的知名科学专业知识。为K99阶段制定了全面的培训和职业发展计划,其中包括少突胶质细胞/髓鞘生物学和人类神经病理学的进一步科学培训;正式课程和参加当地,国家和国际科学会议;与辅导团队的评估会议;以及旨在提高沟通,写作,教学和管理技能的活动。总的来说,有一个优秀的知识环境,并获得申请人的项目领域,职业发展的多种机会,以及大量的机构承诺的相关专业知识。这种丰富和支持性的环境将使一个非常有前途的年轻科学家能够进一步发展他的研究专业知识,追求他的结构化培训和职业发展计划,并开始他作为一个独立的学术研究者的职业生涯。
英文摘要
DESCRIPTION (provided by applicant): This K99/R00 application provides career development training and a research plan to further the understanding of glial responses in white matter in the context of Alzheimer's disease (AD). The hypothesis to be tested is that a progressive loss of myelin integrity occurs in AD, activating microglia towards a proinflammatory feed-forward loop, which mediates hyperphosphorylation of the microtubule-associated protein tau and traditional AD pathology: neuritic plaques (NP) and neurofibrillary tangles (NFTs). Conventionally considered a disease of the CNS gray matter, AD also has pronounced and progressive deterioration of cerebral white matter. Recent evidence suggests that changes in myelin integrity could be an early factor driving AD pathology, through stimulation of inflammatory microglia activation and subsequent axonal damage. Extensive work has been done to understand the glial response in AD gray matter yet very little is known about microglia activation in AD white matter, despite the fact that we and others have found a more robust activation of microglia and inflammatory response in AD white matter compared to gray matter. No studies have systematically and quantitatively examined myelin changes and inflammatory profiles as a function of disease progression. Our project will fill this gap by using human autopsy tissue and a mouse model that exhibits loss of myelin integrity to test our hypothesis. Our specific aims are: 1) Quantify the relationship between myelin integrity, microglia activation, proinflammatory cytokine levels, and traditional measures of AD burden (NPs and NFTs) in the white matter of autopsy samples; 2) Determine if loss of myelin integrity, induced by mutation in PLP, in hTau mice will accelerate hyper-phosphorylated tau pathology, and if this pathology can be rescued by suppressing the chronic neuroinflammation using a glia cytokine inhibitor. This project takes advantage of a strong scientific environment and extensive resources at the University of Kentucky, including the Alzheimer's Disease Center, clinically well-characterized autopsy cases that span the disease pathology continuum, and renowned scientific expertise of an enthusiastic and committed mentoring team. A comprehensive training and career development plan has been developed for the K99 phase that includes further scientific training in oligodendrocyte/myelin biology and human neuropathology; formal coursework and participation in local, national and international scientific meetings; evaluative meetings with th mentoring team; and activities designed to improve communication, writing, teaching, and management skills. Overall, there is an outstanding intellectual environment and access to relevant expertise in the applicant's project area, multiple opportunities for career growth, and substantial institutional commitment. This rich and supportive environment will enable a highly promising young scientist to further develop his research expertise, pursue his structured training and career development plan, and launch his career as an independent academic investigator.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drug repurposing for Alzheimer’s disease-related inflammation caused by a TBI
  • 批准号:
    10590132
  • 项目类别:
  • 资助金额:
    $22.95万
  • 财政年份:
    2023
  • 负责人:
    ADAM D BACHSTETTER
  • 依托单位:
Neuronal IL-1R1 Signaling in Mild Closed Head Injury
  • 批准号:
    10518172
  • 项目类别:
  • 资助金额:
    $44.24万
  • 财政年份:
    2022
  • 负责人:
    ADAM D BACHSTETTER
  • 依托单位:
Neuronal IL-1R1 Signaling in Mild Closed Head Injury
  • 批准号:
    10656547
  • 项目类别:
  • 资助金额:
    $42.91万
  • 财政年份:
    2022
  • 负责人:
    ADAM D BACHSTETTER
  • 依托单位:
Translational Approaches to Mitigate Enhanced Alzheimer’s Disease Risk Following a Mild TBI
  • 批准号:
    10090757
  • 项目类别:
  • 资助金额:
    $114.75万
  • 财政年份:
    2021
  • 负责人:
    ADAM D BACHSTETTER
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究